Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vital dyes in sentinel node localization.

P J Bostick1, A E Giuliano

  • 1Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.

Seminars in Nuclear Medicine
|February 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FOXC1: an emerging marker and therapeutic target for cancer.

Oncogene·2017
Same author

FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.

Oncogene·2016
Same author

Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2014
Same author

Assessment of DNA methylation status in early stages of breast cancer development.

British journal of cancer·2013
Same author

FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.

Oncogene·2012
Same author

Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis.

Breast (Edinburgh, Scotland)·2009
Same journal

Letter from the Editors.

Seminars in nuclear medicine·2026
Same journal

Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

Seminars in nuclear medicine·2026
Same journal

The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.

Seminars in nuclear medicine·2026
Same journal

Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

Seminars in nuclear medicine·2026
Same journal

<sup>18</sup>F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.

Seminars in nuclear medicine·2026
Same journal

Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.

Seminars in nuclear medicine·2026
See all related articles

Blue dyes enable accurate sentinel lymph node (SN) mapping in cancer surgery. Combining blue dye with radiopharmaceuticals and gamma probes enhances SN localization for improved cancer staging and treatment.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Medical Imaging

Background:

  • Sentinel lymph node dissection (SLND) is crucial for cancer staging.
  • Accurate localization of the sentinel node (SN) is essential for successful SLND.
  • Current methods for SN mapping include vital blue dyes and radiopharmaceutical agents.

Purpose of the Study:

  • To evaluate the feasibility and accuracy of intraoperative lymphatic mapping using vital blue dyes for sentinel node (SN) identification.
  • To explore the complementary role of radiopharmaceutical agents and gamma probes in enhancing SN localization.
  • To discuss the future implications of SLND in managing melanoma, breast cancer, and other solid tumors.

Main Methods:

  • Utilized vital blue dyes for direct visualization of lymphatic pathways to the SN.

Related Experiment Videos

  • Employed preoperative lymphoscintigraphy to pre-identify SN location.
  • Integrated intraoperative gamma probe detection with blue dye visualization for dual-modality mapping.

    • Main Results:

    • Vital blue dyes alone can effectively localize the SN after sufficient surgical experience.
    • Radiopharmaceutical agents combined with gamma probes offer enhanced intraoperative SN detection.
    • Further research is needed to fully elucidate the intralymphatic kinetics of radiopharmaceutical agents.

    Conclusions:

    • Intraoperative lymphatic mapping using blue dye is a feasible and accurate technique for SN identification in various solid tumors.
    • The combination of blue dye with radiotracers and gamma probe technology improves SN localization accuracy.
    • Ongoing clinical trials will further define the role of SLND in oncologic management.